SCHEMBL15216634

SCHEMBL15216634

CCCCCCCCCCCCCCCCCC[N+](CCCCCCCCCCCCCCCCCC)(C(C)O)C(O)CO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 1/20 0.41
DNM1 Q05193 4/20 0.41
TP53 P04637 2/20 0.39
CYP3A4 P08684 2/20 0.39
ALDH1A1 P00352 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
ALOX12 P18054 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HIF1A Q16665 1/20 0.39
HSD17B10 Q99714 1/20 0.39
LMNA P02545 2/20 0.39
HTT P42858 2/20 0.38
CYP2D6 P10635 2/20 0.37
SPHK1 Q9NYA1 1/20 0.37
GMNN O75496 1/20 0.37
POLB P06746 1/20 0.37
THPO P40225 1/20 0.37
MTOR P42345 1/20 0.37
BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12322667 0.90 SLC22A1 (0.46) SLC22A1DNM1TP53CYP3A4ALDH1A1
Bromide SCHEMBL557385 0.83 ALDH1A1 (0.52) SLC22A1DNM1TP53CYP3A4ALDH1A1
Hydrochloric Acid SCHEMBL2772679 0.83 DNM1 (0.48) SLC22A1DNM1TP53CYP3A4ALDH1A1
Hydrochloric Acid SCHEMBL4603559 0.83 DNM1 (0.48) SLC22A1DNM1TP53CYP3A4ALDH1A1
Water SCHEMBL17222518 0.83 SLC22A1 (0.48) SLC22A1DNM1TP53CYP3A4ALDH1A1
Hydrochloric Acid SCHEMBL2764924 0.82 DNM1 (0.43) SLC22A1DNM1TP53CYP3A4ALDH1A1
Hydrochloric Acid SCHEMBL315435 0.79 DNM1 (0.44) SLC22A1DNM1TP53CYP3A4ALDH1A1
SCHEMBL17222516 0.76 SLC22A1 (0.41) SLC22A1DNM1TP53CYP3A4ALDH1A1
SCHEMBL8500577 0.75 SLC22A1 (0.43) SLC22A1DNM1TP53CYP3A4ALDH1A1
Octane SCHEMBL23406315 0.75 TDP1 (0.62) SLC22A1TP53CYP3A4ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130225663-A1 LIPID DELIVERY FORMULATIONS DICERNA PHARMACEUTICALS, INC. (US) 2013-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225663-A1 LIPID DELIVERY FORMULATIONS LIPA, LIPC, CETP SLC22A1 740/4885DNM1 1763/4885TP53 2251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.